EBOS Group Limited (EBOSF)

28.25 0.00 (0.00%) At close: 01:12PM EST

EBOS Group Limited

737 Bourke Street
Level 7
Docklands, VIC 3008
Australia
61 3 9918 5555
https://www.ebosgroup.com

Sector(s): Healthcare
Industry: Medical Distribution
Full-time employees: 5,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. John Cullity	Chief Executive Officer	4.08M	N/A	N/A
Mr. Leonard Hansen	CFO & Chief Accountant	N/A	N/A	N/A
Mithran Naiker	Chief Information Officer	N/A	N/A	N/A
Ms. Janelle Cain	General Counsel	N/A	N/A	N/A
Ms. Jacinta McCarthy	Group General Manager of Human Resources	N/A	N/A	N/A
Mr. Simon Bunde	Executive General Manager of Strategic Operations, ESG & Innovation	N/A	N/A	N/A
Ms. Julie Dillon	Chief Executive Officer of Animal Care	N/A	N/A	N/A
Mr. Matthew Muscio	Chief Executive Officer of Medical Technology	N/A	N/A	N/A
Mr. Brett Barons	Chief Executive Officer of Symbion	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Corporate governance

EBOS Group Limited’s ISS governance QualityScore as of 1 December 2023 is 9. The pillar scores are Audit: 5; Board: 9; Shareholder rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.